EFPIA welcomes today's European Court of Justice ruling in the Medeva case

News & Events

The EFPIA view

EFPIA welcomes today's European Court of Justice ruling in the Medeva case

24.11.11

The interpretation of the CJEU takes as back to the original intent of the SPC scheme: to stimulate innovation. The much narrower interpretation by the UK court disregarded the fact that components that are patented, such as one part of a combination vaccine, should be protected also when used in a combination. EFPIA welcomes this ruling as it creates clarity and confirms the importance of the SPC also when used in combinations. To read the judgement of the Court, click here...